Because the biological activity of these mature IL-33 variants is 30- to 60-fold greater than that of full-length IL-33, we used human microvascular endothelial cells (HRMVECs) and mouse oxygen-induced retinopathy models to investigate the influence of each of these IL-33 variants on angiogenesis. This evidence concerns the gene IL33 and retinal disorder.